Excellence in Protein Engineering – Awards & Recognition

News

May 6, 2021 01:05 PM

Codexis Reports First Quarter 2021 Financial Results

April 22, 2021 01:05 PM

Codexis to Report First Quarter 2021 Financial Results on May 6

February 25, 2021 01:05 PM

Codexis Reports Fourth Quarter and Fiscal Year 2020 Financial Results

February 9, 2021 01:05 PM

Codexis Announces Expansion to New Facility to Accommodate Next Stage of Growth

February 3, 2021 01:05 PM

Codexis Appoints Dr. Esther Martinborough to its Board of Directors

January 13, 2021 04:00 AM

Codexis Introduces Improved Enzymes to Further Enhance Tate & Lyle’s Stevia and Allulose Production

December 2, 2020 08:10 PM

Codexis Announces Pricing of Public Offering of Common Stock

November 24, 2020 02:01 PM

Codexis and Casdin Capital Launch SynBio Innovation Accelerator

November 5, 2020 01:05 PM

Codexis Reports Third Quarter 2020 Financial Results

August 6, 2020 04:00 AM

Codexis Adds Dr. Jennifer L. Aaker to its Board of Directors

August 1, 2020 01:05 PM

Codexis Reports Second Quarter 2020 Financial Results

June 23, 2020 04:00 AM

Codexis and Molecular Assemblies Partner to Transform the Field of DNA Synthesis

June 16, 2020 01:05 PM

Codexis Announces the Election of New Directors at its Annual Meeting of Stockholders

June 1, 2020 01:05 PM

Codexis and Alphazyme Partner to Offer Novel Enzymes to Life Science and Diagnostic Markets

May 7, 2020 01:05 PM

Codexis Reports First Quarter 2020 Financial Results

May 6, 2020 01:05 PM

Codexis Achieves Technology Transfer Milestone with Global Pharmaceutical Leader

May 5, 2020 04:00 AM

Codexis Expands and Strengthens its Leadership Team with Two Executive Hires

March 23, 2020 04:00 AM

Codexis Signs Strategic Collaboration and License Agreement with Takeda to Advance Novel Gene Therapies for Rare Genetic Disorders

February 27, 2020 01:05 PM

Codexis Reports 2019 Fourth Quarter and Full Year Financial Results

January 10, 2020 04:00 AM

Codexis and Nestlé Health Science Sign Development Agreement to Advance Therapeutic Candidate towards Clinical Studies and Extend Strategic Collaboration Agreement

December 23, 2019 04:00 AM

Codexis Announces License Agreement with Roche for Enzyme Used in Next Generation Sequencing

December 5, 2019 01:05 PM

Codexis Announces the Publication with Merck of an Efficient Enzymatic Cascade Process for Synthesis of Investigational Anti-HIV Agent, Islatravir

October 15, 2019 01:05 PM

Codexis’ Protein Engineering Forum Highlights Progress and Future Direction of the Field

August 6, 2019 01:04 PM

Codexis Names Ross Taylor Senior Vice President and Chief Financial Officer

June 20, 2019 04:00 AM

Casdin Capital Invests $50 Million in Codexis to Accelerate Strategic Growth Initiatives

May 15, 2019 06:00 AM

Codexis Announces CodeEvolver® Technology Transfer and License Agreement with Global Pharmaceutical Leader

April 30, 2019 04:00 AM

Codexis Signs Multi-Year Enzyme Supply and Licensing Agreement with Tate & Lyle for the Manufacture of TASTEVA® M Stevia Sweetener

February 26, 2019 01:05 PM

Codexis Reports 2018 Fourth Quarter and Full Year Financial Results

February 14, 2019 04:00 AM

Codexis Announces Nestlé Health Science Exercises Option for Exclusive Global License to CDX-6114 for the Management of Phenylketonuria

February 6, 2019 04:00 AM

Codexis Announces Enzyme Supply Agreement with KYORIN Pharmaceutical for Overactive Bladder Drug Sold in Japan

February 4, 2019 01:05 PM

Codexis Secures Multi-Year Technology Upgrade Package for its CodeEvolver Protein Engineering Platform License with Merck

November 8, 2018 04:00 AM

Codexis Announces Results of Phase 1a Clinical Trial with CDX-6114

April 23, 2018 03:00 AM